Matches in SemOpenAlex for { <https://semopenalex.org/work/W2476519806> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2476519806 abstract "Survivin is a bifunctional protein that acts as a suppressor of apoptosis and plays a central role in cell division. The protein is strongly expressed in the most common human neoplasms, has prognostic relevance for some of them, and appears to be involved in tumour cell resistance to anticancer agents and ionizing radiation. On the basis of these findings, survivin has been proposed as an attractive target for new anticancer interventions. We generated a hammerhead ribozyme (Rz) targeting the CUA110 triplet in the survivin mRNA and transfected them into the JR8 human melanoma cell line. Cells endogenously expressing Rz were characterized by a lower survivin protein level than parental cells, and showed an increased caspase-9-dependent apoptotic response to treatment with the cytotoxic agents cisplatin and topotecan as well as with ɣ-irradiation. Moreover, an increased anti-tumour activity of oral topotecan was observed in Rz-expressing cells grown as xenograft tumours in athymic nude mice. In addition, we constructed a Moloney-based retroviral vector expressing Rz, encoded as a chimeric RNA within adenoviral VA1 RNA. Polyclonal cell populations, obtained by infection with the retroviral vector, of two androgen-independent human prostate cancer cell lines (DU145 and PC-3) were characterized by a significant reduction of survivin expression; the cells became polyploid and underwent caspase-9-dependent apoptosis. Survivin inhibition also enhanced their susceptibility to cisplatin-induced apoptosis and prevented tumour formation when cells were xenografted into athymic nude mice. Again we used RNAi to specifically repress survivin in DU145 and PC-3 cell lines. RNAi-mediated survivin knock-down was able to significantly reduce cell proliferation and to enhance the rate of caspase-9-dependent apoptosis. Moreover, sequential treatment with survivin-specific siRNA followed by the Hsp90 inhibitor 17-allylamino-17-demethoxy-geldanamycin produced supra-additive anti-proliferative effects in both cell lines. Finally, we investigated the effects of the novel cdk inhibitor NU6140, in term of ability to potentiate the response to paclitaxel in HeLa cells, in relation to its interference with survivin. Sequential administration of cdk inhibitors resulted in escape from the mitotic block imposed by paclitaxel and significantly increased the apoptotic rate, with inhibition of survivin expression/phosphorylation as the potential mechanism. Overall, such results suggest that strategies aimed at interfering with survivin expression/activity can be adopted to improve the chemo/radio-sensitivity profile of treatment-refractory human malignancies." @default.
- W2476519806 created "2016-08-23" @default.
- W2476519806 creator A5038502087 @default.
- W2476519806 date "2008-03-24" @default.
- W2476519806 modified "2023-09-27" @default.
- W2476519806 title "Strategies for surviving down-regulation : effects on tumour cell growth potential and chemosensitivity profile" @default.
- W2476519806 doi "https://doi.org/10.21954/ou.ro.0000fd56" @default.
- W2476519806 hasPublicationYear "2008" @default.
- W2476519806 type Work @default.
- W2476519806 sameAs 2476519806 @default.
- W2476519806 citedByCount "0" @default.
- W2476519806 crossrefType "dissertation" @default.
- W2476519806 hasAuthorship W2476519806A5038502087 @default.
- W2476519806 hasConcept C104317684 @default.
- W2476519806 hasConcept C121608353 @default.
- W2476519806 hasConcept C153911025 @default.
- W2476519806 hasConcept C166703698 @default.
- W2476519806 hasConcept C173396325 @default.
- W2476519806 hasConcept C185592680 @default.
- W2476519806 hasConcept C190232843 @default.
- W2476519806 hasConcept C190283241 @default.
- W2476519806 hasConcept C2775975398 @default.
- W2476519806 hasConcept C2776438761 @default.
- W2476519806 hasConcept C2776694085 @default.
- W2476519806 hasConcept C2778239845 @default.
- W2476519806 hasConcept C2779723316 @default.
- W2476519806 hasConcept C502942594 @default.
- W2476519806 hasConcept C54009773 @default.
- W2476519806 hasConcept C54355233 @default.
- W2476519806 hasConcept C55493867 @default.
- W2476519806 hasConcept C67705224 @default.
- W2476519806 hasConcept C81885089 @default.
- W2476519806 hasConcept C86803240 @default.
- W2476519806 hasConcept C96232424 @default.
- W2476519806 hasConceptScore W2476519806C104317684 @default.
- W2476519806 hasConceptScore W2476519806C121608353 @default.
- W2476519806 hasConceptScore W2476519806C153911025 @default.
- W2476519806 hasConceptScore W2476519806C166703698 @default.
- W2476519806 hasConceptScore W2476519806C173396325 @default.
- W2476519806 hasConceptScore W2476519806C185592680 @default.
- W2476519806 hasConceptScore W2476519806C190232843 @default.
- W2476519806 hasConceptScore W2476519806C190283241 @default.
- W2476519806 hasConceptScore W2476519806C2775975398 @default.
- W2476519806 hasConceptScore W2476519806C2776438761 @default.
- W2476519806 hasConceptScore W2476519806C2776694085 @default.
- W2476519806 hasConceptScore W2476519806C2778239845 @default.
- W2476519806 hasConceptScore W2476519806C2779723316 @default.
- W2476519806 hasConceptScore W2476519806C502942594 @default.
- W2476519806 hasConceptScore W2476519806C54009773 @default.
- W2476519806 hasConceptScore W2476519806C54355233 @default.
- W2476519806 hasConceptScore W2476519806C55493867 @default.
- W2476519806 hasConceptScore W2476519806C67705224 @default.
- W2476519806 hasConceptScore W2476519806C81885089 @default.
- W2476519806 hasConceptScore W2476519806C86803240 @default.
- W2476519806 hasConceptScore W2476519806C96232424 @default.
- W2476519806 hasLocation W24765198061 @default.
- W2476519806 hasOpenAccess W2476519806 @default.
- W2476519806 hasPrimaryLocation W24765198061 @default.
- W2476519806 hasRelatedWork W1498811123 @default.
- W2476519806 hasRelatedWork W1527782622 @default.
- W2476519806 hasRelatedWork W1975906321 @default.
- W2476519806 hasRelatedWork W2003126314 @default.
- W2476519806 hasRelatedWork W2012643682 @default.
- W2476519806 hasRelatedWork W2044154757 @default.
- W2476519806 hasRelatedWork W2081934185 @default.
- W2476519806 hasRelatedWork W2097434817 @default.
- W2476519806 hasRelatedWork W2104883825 @default.
- W2476519806 hasRelatedWork W2152095899 @default.
- W2476519806 hasRelatedWork W2159271922 @default.
- W2476519806 hasRelatedWork W2168042612 @default.
- W2476519806 hasRelatedWork W2258180175 @default.
- W2476519806 hasRelatedWork W2380984092 @default.
- W2476519806 hasRelatedWork W269091000 @default.
- W2476519806 hasRelatedWork W2794367218 @default.
- W2476519806 hasRelatedWork W2810356027 @default.
- W2476519806 hasRelatedWork W2885480394 @default.
- W2476519806 hasRelatedWork W3190154804 @default.
- W2476519806 hasRelatedWork W2170872314 @default.
- W2476519806 isParatext "false" @default.
- W2476519806 isRetracted "false" @default.
- W2476519806 magId "2476519806" @default.
- W2476519806 workType "dissertation" @default.